Doctors underutilize next-gen antibiotics to fight resistant infections in U.S. hospitals - National Institutes of Health (NIH) (.gov)

Media Advisory

Friday, April 19, 2024

NIH scientists find clinicians still rely often on older and toxic medicines.

What

Despite Food and Drug Administration (FDA)-approval of seven next-generation antibiotics to fight infections caused by resistant "gram-negative" bacteria, clinicians frequently continue to treat antibiotic-resistant infections with older generic antibiotics considered to be less effective and less safe, according to a study by researchers at the National Institutes of Health's (NIH) Clinical Center. Researchers examined the factors influencing doctors' preference for newer antibiotics over traditional generic agents to shed light on the decision-making processes among clinicians when treating patients with challenging bloodstream infections caused by gram-negative bacteria and significant comorbidities.

The study revealed that at a considerable proportion of hospitals, particularly smaller facilities located in rural areas, staff were reluctant to adopt newer antibiotics. Researchers identified a large cost disparity between older and newer classes of antibiotics; the newer drugs can cost approximately six times more than the older medications, which could disincentivize prescribing.

Researchers also highlight that next-gen agents are prescribed more often at hospitals where lab results that show the medications are effective against a patient's bacterial infection are reported to prescribers. Scientists suggest that earlier and more widespread availability of such lab testing might improve use. Additionally, authors recommend that future public health policies and economic strategies on further development and use of similar antibiotics should be designed to identify and overcome additional barriers.

Gram-negative bacteria are a class of bacteria resistant to multiple drugs and increasingly resistant to most antibiotics. According to the Centers for Disease Control and Prevention, they are able to find new paths of resistant and pass along genetic material that enables other bacteria to become drug resistant.

This study was funded by the FDA and the NIH Intramural Research Program.

Who

Sameer S. Kadri, M.D., head of the Clinical Epidemiology Section, NIH Clinical Center

Article

Sameer S. Kadri, MD, et al. Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals. Annals of Internal Medicine. April 19, 2024. DOI: 10.7326/M23-2309.

About the NIH Clinical Center: America's research hospital, is located on the NIH campus in Bethesda, Md. Through clinical research, clinician-investigators translate laboratory discoveries into better treatments, therapies and interventions to improve the nation's health.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH…Turning Discovery Into Health®

###

Adblock test (Why?)

Comments

Post a Comment

Popular posts from this blog

Blood Clots Per Rectum in a Pediatric Patient With Salmonella Enteritis: A Case Report - Cureus

Image
Infection is a common cause of hematochezia in children. While infectious diarrhea can present with bloody stools, it is rare to have the passage of frank blood clots per rectum in the pediatric population. This is a case of a seven-year-old male who presented with vomiting, diarrhea, severe abdominal pain, and passage of blood clots per rectum. As symptoms progressed, consideration of non-infectious causes was investigated and subsequently ruled out. The stool polymerase chain reaction (PCR) was positive for Salmonella species, while stool culture was negative for any enteropathogen. This report highlights the unusual occurrence of the passage of blood clots per rectum in a child with salmonella enterocolitis. Introduction Acute gastroenteritis is a frequent cause of outpatient visits and hospitalizations in the USA, causing about 500,000 hospitalizations, and more than 5,000 deaths. While the most common cause of hematochezia in the pediatric population is infectious, a var...
Read more

Mysterious Morel Mushrooms at Center of Food Poisoning Outbreak - Kaiser Health News

Image
A food poisoning outbreak that killed two people and sickened 51, stemming from a Montana restaurant, has highlighted just how little is known about morel mushrooms and the risks in preparing the popular and expensive delicacy. The FDA conducted an investigation into morel mushrooms after the severe illness outbreak linked to Dave's Sushi in Bozeman in late March and April. The investigation found that undercooked or raw morels were the likely culprit, and it led the agency to issue its first guidelines on preparing morels. "The toxins in morel mushrooms that may cause illness are not fully understood; however, using proper preparation procedures, such as cooking, can help to reduce toxin levels," according to the FDA guidance. Even then, a risk remains, according to the FDA: "Properly preparing and cooking morel mushrooms can reduce risk of illness, however there is no guarantee of safety even if cooking steps a...
Read more